Although genome-wide association studies (GWASs) have identified many risk loci for 2 complex traits and common diseases, most of the identified associations reside in 3 noncoding regions and have unknown biological functions. Recent genomic sequencing 4 studies have produced a rich resource of annotations that help characterize the function of 5 genetic variants. Integrative analysis that incorporates these functional annotations into 6 GWAS can help elucidate the biological mechanisms underlying the identified associations 7 and help prioritize causal-variants. Here, we develop a novel, flexible Bayesian variable 8 selection model with efficient computational techniques for such integrative analysis. 9 Different from previous approaches, our method models the effect-size distribution and 3 1 wide variants. Our method improves the MCMC convergence property to ensure accurate 3 2 Bayesian inference of the quantifications of the functional enrichment pattern and fine-3 3 mapped association results. By applying our method to the real GWAS of age-related 3 4 macular degeneration (AMD) with various functional annotations (i.e., gene-based, 3 5
1 0 probability of causality for variants with different annotations and jointly models genome-1 1 wide variants to account for linkage disequilibrium (LD), thus prioritizing associations based 1 2 on the quantification of the annotations and allowing for multiple causal-variants per locus. human genomes. With simulations, we show that our method accurately quantifies the 1 6 functional enrichment and performs more powerful for identifying true causal-variants than 1 7 several competing methods. The power gain brought up by our method is especially 1 8 apparent in cases when multiple causal-variants in LD reside in the same locus. We also Introduction 4 9 6 function at 0. Here, ߨ represents the (unknown) causal probability for variants in the ‫ݍ‬ th 1 0 0 category and ߪ ଶ represents the (unknown) corresponding effect-size variance. An 1 0 1 enhancement to previous Bayesian models [33] [34] [35] is that we model both the proportion of 1 0 2 associated variants and their effect-size distribution in each annotation category. Our goal is to simultaneously make inference on category specific parameters information among genome-wide to estimate category specific parameters, which then 1 0 8
inform the variant specific parameters. As a result, variant associations will be prioritized 1 0 9
based on the inferred importance of functional categories. structure along the human genome [28] [29] [30] 36, 37] . This observation allows us to decompose 1 1 5 the complex joint likelihood of our model into a product of block-wise likelihoods (Online 1 1 6
Methods and Text S1). Intuitively, conditional on a common set of category specific block. A diagram of this EM-MCMC algorithm is shown in Fig S1(b) .
Running MCMC per genome-block facilitates parallel computing and reduces the 1 2 0 search space. Unlike previous MCMC algorithms for GWAS that use proposal distributions block that is the proportion of MCMC iterations with at least one "causal" variant (see Text 1 3 9 S1). Because Bayesian PP might be split among multiple variants in high LD, the threshold 1 4 0 of regional-PP >0.95 (conservatively analogous to false discovery rate 0.05) is used for 1 4 1 identifying loci. S12(a)), we found that non-synonymous category were 54x more likely to be causal (P- ); that coding-synonymous and other variants were 4.3x and 2.2x more 3 0 1 likely (P-values = 0.005, 0.003); and that intergenic 0.7x less likely (P-value=4.9 ൈ 1 0 ି ); 3 0 2 while the intronic variants matched the genome-wide average (P-value=0.659 ). In addition, ; Fig S12(b) ), we 3 0 4
found that the effect size variance of was 1.9x larger for non-synonymous variants (P-3 0 5
value=0.014; i.e., 1.4x larger effect-size); and 0.4x smaller for variants in the intronic annotations is not as pronounced as by bfGWAS (Fig S11(a) ). Second, we analyzed the GWAS data of AMD with the summarized regulatory of the previous six categories). Overall GWAS results were similar as the ones described in 3 1 6 previous context (Tables S7-S10 ). Compared to the genome-wide average association Fig S12(c) ), we found that the association probability of the With each set of chromatin states profiled in one cell type, we applied bfGWAS on 3 4 2 the GWAS data of AMD, and then examined the list of variants that contribute 95% 3 4 3 posterior probabilities in the identified loci with regional-PP >95%. We found that the results analysis results of other cell types were slightly different (Figs S13-S15). Here, we present the results of accounting for the chromatin states profiled in the 3 4 8 K562 cell type (Fig 3(e, f) ; Tables S11-S14 the CNV category (P-values = 0.004). In addition, the effect-size variances of associated 3 5 4 variants in active promoter and strong enhancer were found 2x larger than the genome- weak enhancer, transcription elongation, and CNV categories were not significantly 3 5 7 different (P-values >0.1; Fig S12(f) ).
3 5 8
Note that the Bayesian enrichment estimates of the poised promoter and insulator categories are the same as their priors (not plotted in Fig 3(e, f) ), suggesting that bfGWAS
identified no associations in these two categories. Again, Fgwas identified a similar 3 6 1 enrichment pattern ( Fig S11(c) ). By simulation studies, we demonstrated that bfGWAS had higher power than Fgwas 3 7 4 and conditioned P-value for identifying multiple signals in a single locus by accounting for 3 7 5
both functional information and LD. We also showed that bfGWAS accurately estimated the 3 7 6
enrichment patterns under scenarios with or without enrichment for one annotation in simulations. In the real analysis using the AMD GWAS data and three different types of 3 7 8
annotations, by bfGWAS, we obtained posterior association probabilities and effect-size variances for variants of considered annotation categories, as well as an improved list of 3 8 0
fine-mapped association signals. In addition, we replicated the findings of 32 out of 34 believe our method is useful for understanding the underlying genetic architecture of 3 8 5 complex traits and diseases, for efficiently integrating functional information into GWASs. Our flexible framework allows for many further extensions. For example, it can be 3 8 8
extended to deal with overlapping or quantitative annotations (Text S1). These extensions 3 8 9
will allow us to investigate the importance of a broader class of annotations (e.g. Combined
Annotation Dependent Depletion (CADD) scores, MAF, and eQTL evidence). Importantly, annotations, simultaneous modeling of available annotations will be critical to identify the 3 9 3 set of annotations that are important for a specific trait. Then extending bfGWAS to select relevant annotations would be useful. bfGWAS makes a key assumption that the variant correlation matrix has a block-3 9 6
wise structure, which allows us to segment the genome into approximately independent 3 9 7 blocks, analyze variants per block by MCMC, and summarize genome-wide information by 3 9 8
an EM algorithm. In parallel to our study, many recent studies have also explored the overlapping and continuous annotations (Text S1). We assume a Bayesian hierarchical framework[34] of BVSR with the following 4 3 6 independent hyper priors: that ߬ is fixed at the phenotype variance value in our Bayesian inferences (Text S1). Equivalently, For the described Bayesian hierarchical model above, the posterior joint distribution 4 5 5 is proportional to The basic idea of the EM-MCMC algorithm is to segment the whole genome into estimates, i.e., MAPs) converge ( Fig S1) .
We derive the log-posterior-likelihood functions for As a result, this MCMC algorithm encourages our method to explore different combinations 4 9 0 of potentially causal variants in each locus, and significantly improves the mixing property. We used the potential scale reduction factor (PSRF) [56] to quantitatively diagnose range of (0.9, 1.2), suggesting that our MCMC algorithm has greatly improved mixing We employ two computational technics to save memory in the bfGWAS software.
0 3
One is to save all genotype data as unsigned characters in memory, because unsigned 5 0 4
characters are equivalent to unsigned integers in (0, 256) that can be easily converted to ~3.6GB, for a typical GWAS dataset with ~33K individuals and ~500K variants.
The bfGWAS software wraps a C++ executable file for the E-step (MCMC algorithm)
and an R script for the M-step together by a Makefile, which is generated by a Perl script formulas for the MAPs. In this paper, the Fgwas results were generated by using summary statistics from 5 2 0 single variant likelihood-ratio tests and the same annotation information used by bfGWAS. convergence, we used segment size of 2,000 variants for Fgwas in both simulations and 5 2 4 real data analyses. As a result, the final Fgwas PP is given by the product of the variant- specific PP and the corresponding segment-specific PP, and the Fgwas regional-PP is 5 2 6
given by the highest segment-specific PP in a region or genome block.
2 7
Simulation data 5 2 8
We used genotype data on Chromosome 20-22 from the AMD GWAS (33,976 variants account for ~1% overall variants but ~10% variants within the causal loci (matching SNPs. We controlled the enrichment-fold of coding variants by varying the number of 5 4 0 coding variants among these 100 causal SNPs.
4 1
We compared bfGWAS with P-value, conditioned P-value, and Fgwas. In the 5 4 2 simulation studies, P-values were obtained from a series of likelihood-ratio tests based on 2,000 variants (selected to avoid convergence issues). We failed to include PAINTOR in the hours (on a 2.5GHz, 64-bit CPU) and is thus expected to require >1 million CPU hours for a 5 4 9
genome-wide analysis. In the GWAS data of AMD, the advanced AMD cases -including wet cases with resulting a total of 12,023,830 variants.
6 2
The software bfGWAS used dosage genotype data and standardized phenotypes. Phenotypes were first coded quantitatively with 1's for cases and 0's for controls; second 5 6 4
corrected for the first and second principle components, age, gender, and source of DNA 5 6 5 samples; and then standardized to have mean 0 and standard deviation 1. In order to make 5 6 6
the Bayesian inferences scalable to the AMD GWAS data (33,976 individuals, 9,866,744 5 6 7 variants with MAF >0.5%), we segmented the whole genome into 1,063 non-overlapped 5 6 8 blocks, such that each block has length ~2.5Mb (containing ~10,000 variants) and all 5 6 9
previously identified loci along with variants in LD (R 2 >0.1) were not split. Then we applied extra burn-ins). For comparison, P-values were obtained by a series of likelihood-ratio tests, using 5 7 3
the same "quantitative" phenotype vector as used by bfGWAS; Fgwas was implemented 5 7 4
with the summary statistics from single variant tests and the segment size of 2,000 variants 5 7 5
(resulting 4,934 segments); and a standard Bayesian variable selection regression (BVSR) 5 7 6
method that models no functional information was also applied.
7 7
Three types of genomic annotations were considered for analyzing the AMD data: from chromHMM [19, 42, 43] . For variants annotated with multiple functions, we used the (https://github.com/yjingj/bfGWAS). evidence, hence it has a wide 95% error bar. Table S1-S17. Tables S1-S17. Text S1. Supplementary text containing more details about the bfGWAS method. PSRF within (0.9, 1.2) suggests good mixing property. Fgwas, and bfGWAS with various sample sizes. conditioning on the top significant variant (SNP1 or a proxy for SNP1) that is in high LD with 6 3 0 SNP2. the 95% confidence interval covers 0, while enrichment for coding is estimated with the 6 3 5 95% confidence interval above 0. 
